Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III inhaled mannitol versus placebo in non-cystic fibrosis bronchiectasis
NL-OMON34341Phase 3Active, not recruiting
- Sponsor
- Pharmaxis
- Start
- Feb 2011
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bronchiectasis comparing Inhaled mannitol with Placebo control (2 arms). Primary endpoint: Pulmonary exacerbation rates. Started Feb 2011; status: active, not recruiting.
02
Drugs
Bronchitol
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NL-OMON34341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34341.